DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Elspar (Asparaginase) - Current Clinical Trials

 
 



Elspar Related Clinical Trials

Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML) [Recruiting]

Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia [Active, not recruiting]

Erwinase Study in Patients With Acute Lymphoblastic Leukemia [Completed]

GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia [Active, not recruiting]

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase [Recruiting]

L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma [Completed]

L-asparaginase Encapsulated in Red Blood Cells for Frontline Therapy of Patients With Phi-neg ALL Older Than 40 yo [Recruiting]

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy [Completed]

Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage [Completed]

Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) [Terminated]

Erwinase Master Treatment Protocol [No longer available]

Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008 [Active, not recruiting]

Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL) [Withdrawn]

Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma [Completed]

An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze« (Asparaginase Erwinia Chrysanthemi)/Erwinase« (Crisantaspase) [Withdrawn]

Intensified Post Remission Therapy Containing PEG-Asparaginase [Completed]

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Terminated]

Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses [Recruiting]

New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma [Recruiting]

Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) [Recruiting]

Phase I Study of mPEG-R-Crisantaspase Given IV [Completed]

A Study in Adults With Untreated Acute Lymphoblastic Leukemia [Active, not recruiting]

Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma [Completed]

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer [Completed]

Multicenter Clinical Trial for Adult Ph-negative ALL. Continuous Treatment With Modification of Cytostatic Drugs Doses Depending on Myelosuppression Severity [Recruiting]

Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL) [Completed]

Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008 [Recruiting]

Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA«) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase [Available]

Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia [Recruiting]

Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma [Recruiting]

PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL [Recruiting]

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia [Completed]

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome [Not yet recruiting]

SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma [Active, not recruiting]

Pharmacokinetics of Asparaginase and Antibody Formation in Interfant-06 [Recruiting]

Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia [Active, not recruiting]

A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia [Recruiting]

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) [Active, not recruiting]

Treatment of Acute Lymphoblastic Leukemia in Children [Active, not recruiting]

Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL) [Recruiting]

A Pilot Study of Oncaspar´┐Ż + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma [Terminated]

Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia [Completed]

Trial of Oncaspar« and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia [Terminated]

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia [Active, not recruiting]

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma [Not yet recruiting]

NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma [Recruiting]

A Study of Children With Refractory or Relapsed ALL [Completed]

MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate [Recruiting]

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia [Completed]

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes [Active, not recruiting]

Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL [Recruiting]

Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies [Recruiting]

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia [Completed]

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Completed]

Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia [Completed]

Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma [Completed]

A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL) [Completed]

Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma [Recruiting]

Treatment of Acute Lymphoblastic Leukemia in Children [Completed]

NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia [Completed]

Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma [Active, not recruiting]

GRASPA Treatment for Patients With Acute Myeloblastic Leukemia [Recruiting]

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Completed]

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase [Recruiting]

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Terminated]

Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Not yet recruiting]

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia [Completed]

ALL Adult Consortium Trial: Adult ALL Trial [Active, not recruiting]

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) [Active, not recruiting]

Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia [Completed]

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia [Completed]

Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia [Completed]

Treatment of Childhood Acute Lymphoblastic Leukemia [Terminated]

Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia [Completed]

Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia [Completed]

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia [Completed]

Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia [Active, not recruiting]

ABT-751 With Chemotherapy for Relapsed Pediatric ALL [Terminated]

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia [Completed]

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma [Active, not recruiting]

Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy [Not yet recruiting]

Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma [Completed]

Decitabine, Vorinostat, and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma That Has Relapsed or Not Responded to Treatment [Completed]

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia [Recruiting]

Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Completed]

CINJALL: Treatment for Children With Acute Lymphocytic Leukemia [Completed]

Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Completed]

Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015